19-47780732-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4BS2
The NM_003009.4(SELENOW):āc.37T>Gā(p.Ter13Glyext*?) variant causes a stop lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000614 in 1,563,138 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 28)
Exomes š: 0.000066 ( 2 hom. )
Consequence
SELENOW
NM_003009.4 stop_lost
NM_003009.4 stop_lost
Scores
1
6
Clinical Significance
Conservation
PhyloP100: 1.18
Genes affected
SELENOW (HGNC:10752): (selenoprotein W) This gene encodes a selenoprotein containing a selenocysteine (Sec) residue, which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element that is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. This protein is highly expressed in skeletal muscle, heart and brain. It belongs to the SelWTH family, which possesses a thioredoxin-like fold and a conserved CxxU (C is cysteine, U is Sec) motif, suggesting a redox function for this gene. Studies in mouse show that this selenoprotein is involved in muscle growth and differentiation, and in the protection of neurons from oxidative stress during neuronal development. A retroprocessed pseudogene of this locus has been identified on chromosome 1. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM4
Stoplost variant in NM_003009.4 Downstream stopcodon found after 39 codons.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SELENOW | NM_003009.4 | c.37T>G | p.Ter13Glyext*? | stop_lost | 2/6 | ENST00000601048.6 | NP_003000.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SELENOW | ENST00000601048.6 | c.37T>G | p.Ter13Glyext*? | stop_lost | 2/6 | 1 | NM_003009.4 | ENSP00000473185.1 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150930Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
3
AN:
150930
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000169 AC: 30AN: 177238Hom.: 0 AF XY: 0.000255 AC XY: 24AN XY: 94154
GnomAD3 exomes
AF:
AC:
30
AN:
177238
Hom.:
AF XY:
AC XY:
24
AN XY:
94154
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000659 AC: 93AN: 1412090Hom.: 2 Cov.: 30 AF XY: 0.000106 AC XY: 74AN XY: 697686
GnomAD4 exome
AF:
AC:
93
AN:
1412090
Hom.:
Cov.:
30
AF XY:
AC XY:
74
AN XY:
697686
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000199 AC: 3AN: 151048Hom.: 0 Cov.: 28 AF XY: 0.0000407 AC XY: 3AN XY: 73664
GnomAD4 genome
AF:
AC:
3
AN:
151048
Hom.:
Cov.:
28
AF XY:
AC XY:
3
AN XY:
73664
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
20
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.37T>G (p.U13G) alteration is located in exon 2 (coding exon 2) of the SEPW1 gene. This alteration results from a T to G substitution at nucleotide position 37, causing the nan (U) at amino acid position 13 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at